{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:06:23Z","timestamp":1792008383669,"version":"4.4.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32DA07097"],"award-info":[{"award-number":["T32DA07097"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R03MH53553"],"award-info":[{"award-number":["R03MH53553"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tourette Syndrome Association"},{"name":"University of Minnesota Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.brainres.2015.09.032","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T01:12:08Z","timestamp":1445217128000},"page":"38-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["\"Hyperglutamatergic cortico-striato-thalamo-cortical circuit\" breaker drugs alleviate tics in a transgenic circuit model of Tourette\u05f3s syndrome"],"prefix":"10.1016","volume":"1629","author":[{"given":"Eric J.","family":"Nordstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie C.","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Clinton R.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2015.09.032_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.brainres.2015.09.032_bib2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/npp.2011.308","article-title":"Impaired sensorimotor gating in unmedicated adults with obsessive\u2013compulsive disorder","volume":"37","author":"Ahmari","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2015.09.032_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.brainres.2015.09.032_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/da.22367","article-title":"Dissecting OCD circuits: from animal models to targeted treatments","volume":"32","author":"Ahmari","year":"2015","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","article-title":"Recent advances in Tourette syndrome research","volume":"29","author":"Albin","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2015.09.032_bib6","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"10","key":"10.1016\/j.brainres.2015.09.032_bib7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/00207450902787165","article-title":"Protection in glutamate-induced neurotoxicity by imidazoline receptor agonist moxonidine","volume":"119","author":"Bakuridze","year":"2009","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.brainres.2015.09.032_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/106002808602001006","article-title":"Safety evaluation of ritanserin--an investigational serotonin antagonist","volume":"20","author":"Barone","year":"1986","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.brainres.2015.09.032_bib9","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awl050","article-title":"Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study","volume":"129","author":"Bohlhalter","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2015.09.032_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/ajp.156.7.1122a","article-title":"Ketanserin treatment of Tourette\u05f3s syndrome in children","volume":"156","author":"Bonnier","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"13","key":"10.1016\/j.brainres.2015.09.032_bib11","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/npp.2011.157","article-title":"Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice","volume":"36","author":"Bortolato","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.brainres.2015.09.032_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1996.01830070041008","article-title":"Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder","volume":"53","author":"Breiter","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2015.09.032_bib13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00003495-199040060-00010","article-title":"Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease","volume":"40","author":"Brogden","year":"1990","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib14","first-page":"29","article-title":"Risperidone as a treatment for Tourette\u05f3s syndrome","volume":"57","author":"Bruun","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1232380","article-title":"Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors","volume":"340","author":"Burguiere","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.brainres.2015.09.032_bib16","series-title":"Animal Models of Movement Disorders","first-page":"441","article-title":"Animal models of Tourette syndrome","author":"Burke","year":"2004"},{"key":"10.1016\/j.brainres.2015.09.032_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/350074a0","article-title":"Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene","volume":"350","author":"Burton","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2015.09.032_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-9384(98)00030-4","article-title":"Detecting subtle differences in behavior using waveform display analysis","volume":"64","author":"Campbell","year":"1998","journal-title":"Physiol. Behav."},{"issue":"12","key":"10.1016\/j.brainres.2015.09.032_bib19","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1523\/JNEUROSCI.19-12-05044.1999","article-title":"OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons","volume":"19","author":"Campbell","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2015.09.032_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(99)00184-3","article-title":"Differential response of cortical-limbic neuropotentiated compulsive mice to D1 and D2 antagonists","volume":"371","author":"Campbell","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(99)01544-9","article-title":"Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion","volume":"833","author":"Campbell","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2015.09.032_bib22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/00001756-200007140-00053","article-title":"TS+OCD-like neuropotentiated mice are supersensitive to seizure induction","volume":"11","author":"Campbell","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2015.09.032_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1600-0447.2000.102006401.x","article-title":"On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions","volume":"102","author":"Carlsson","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.brainres.2015.09.032_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2013.10.052","article-title":"Histidine decarboxylase deficiency causes Tourette syndrome: parallel findings in humans and mice","volume":"81","author":"Castellan Baldan","year":"2014","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.brainres.2015.09.032_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0091-3057(94)00331-9","article-title":"Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and emulphor-620","volume":"50","author":"Castro","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2015.09.032_bib26","first-page":"415","article-title":"Treatment of refractory OCD with the dopamine agonist bromocriptine","volume":"55","author":"Ceccherini-Nelli","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1017385","article-title":"The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam","volume":"18","author":"Ceulemans","year":"1985","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib28","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic Dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0304-3940(03)00637-2","article-title":"Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice","volume":"347","author":"Cheng","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2015.09.032_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jocrd.2014.04.002","article-title":"Pediatric Tourette syndrome: insights from recent neuroimaging studies","volume":"3","author":"Church","year":"2014","journal-title":"J. Obsessive Compuls. Relat. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00239-3","article-title":"Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats","volume":"373","author":"Ciccocioppo","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0193-953X(18)30260-0","article-title":"Pharmacotherapy of Tourette\u05f3s syndrome and associated disorders","volume":"15","author":"Cohen","year":"1992","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib33","first-page":"73","article-title":"Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses","volume":"7","author":"Danjou","year":"1992","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2015.09.032_bib34","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.02.045","article-title":"Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice","volume":"732","author":"Dixit","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1469-7793.1999.00565.x","article-title":"Experiments using transcranial magnetic brain stimulation in man could reveal important new mechanisms in motor control","volume":"521","author":"Edgley","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2015.09.032_bib37","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","article-title":"L-histidine decarboxylase and Tourette\u05f3s syndrome","volume":"362","author":"Ercan-Sencicek","year":"2010","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.brainres.2015.09.032_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3565(24)34914-6","article-title":"Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice","volume":"290","author":"Fairbanks","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2015.09.032_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00213-013-2988-x","article-title":"An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice","volume":"227","author":"Fox","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2015.09.032_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.36.3.378","article-title":"Obsessions and compulsions in Gilles de la Tourette\u05f3s syndrome","volume":"36","author":"Frankel","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0028-3908(93)90110-O","article-title":"Effects of acute and subchronic administration of ritanserin on the social behaviour of mice","volume":"32","author":"Gao","year":"1993","journal-title":"Neuropharmacology"},{"issue":"3\u20134","key":"10.1016\/j.brainres.2015.09.032_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0028-3908(94)90076-0","article-title":"Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects","volume":"33","author":"Gibson","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2015.09.032_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","article-title":"Tourette\u05f3s syndrome improvement with pergolide in a randomized, double-blind, crossover trial","volume":"54","author":"Gilbert","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2015.09.032_bib44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mds.20044","article-title":"Association of cortical disinhibition with tic, ADHD and OCD severity in Tourette Syndrome","volume":"19","author":"Gilbert","year":"2004","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/WNF.0000000000000017","article-title":"A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome","volume":"37","author":"Gilbert","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib46","article-title":"The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement","author":"Godar","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib47","first-page":"245","article-title":"Clonidine and clonazepam in Tourette syndrome","volume":"58","author":"Goetz","year":"1992","journal-title":"Adv. Neurol."},{"issue":"7","key":"10.1016\/j.brainres.2015.09.032_bib48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib49","first-page":"179","article-title":"A single-blind study of\u05f3as-needed\u05f3 ecopipam for gambling disorder","volume":"26","author":"Grant","year":"2014","journal-title":"Ann. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2015.09.032_bib50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/cap.2007.0021","article-title":"An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder","volume":"17","author":"Grant","year":"2007","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"issue":"43","key":"10.1016\/j.brainres.2015.09.032_bib51","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2015.09.032_bib52","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00005344-198700103-00022","article-title":"Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension","volume":"10","author":"Hosie","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00172952","article-title":"The motor effects of bromocriptine--a review","volume":"95","author":"Jackson","year":"1988","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pnpbp.2005.11.006","article-title":"Current animal models of obsessive compulsive disorder: A critical review","volume":"30","author":"Joel","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib56","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","article-title":"Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome","volume":"102","author":"Kalanithi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2015.09.032_bib57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/jmedgenet-2013-101637","article-title":"Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families","volume":"50","author":"Karagiannidis","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.brainres.2015.09.032_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","article-title":"Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome","volume":"518","author":"Kataoka","year":"2010","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2015.09.032_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/088307389601100205","article-title":"Predictors of clonidine response in Tourette syndrome: implications and inferences","volume":"11","author":"Lichter","year":"1996","journal-title":"J. Child. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1461145705005729","article-title":"Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette\u05f3s syndrome (TS)","volume":"9","author":"Mantovani","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2015.09.032_bib62","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0006-3223(98)00036-5","article-title":"The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis","volume":"44","author":"Marek","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.brainres.2015.09.032_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(98)00945-5","article-title":"5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex","volume":"367","author":"Marek","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00008877-199909000-00001","article-title":"Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior","volume":"10","author":"McGrath","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1037\/0735-7044.113.6.1249","article-title":"The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior","volume":"113","author":"McGrath","year":"1999","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2015.09.032_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)02646-9","article-title":"Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette\u05f3s Syndrome and obsessive-compulsive disorder","volume":"877","author":"McGrath","year":"2000","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways","volume":"16","author":"Milad","year":"2012","journal-title":"Trends Cogn. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(01)00262-4","article-title":"Basal ganglia dysfunction in Tourette\u05f3s syndrome: a new hypothesis","volume":"25","author":"Mink","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.brainres.2015.09.032_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2003.12.006","article-title":"Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum","volume":"219","author":"Minzer","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"6617","key":"10.1016\/j.brainres.2015.09.032_bib71","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/385578a0","article-title":"Schizophrenia. An emerging pathophysiology [news; comment]","volume":"385","author":"Nestler","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(98)00591-3","article-title":"5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion","volume":"358","author":"Ninan","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.mp.4001144","article-title":"A transgenic model of comorbid Tourette\u05f3s syndrome and obsessive-compulsive disorder circuitry","volume":"7","author":"Nordstrom","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","article-title":"Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits","volume":"147","author":"Penagarikano","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2015.09.032_bib75","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.43.5.941","article-title":"Reduced basal ganglia volumes in Tourette\u05f3s syndrome using three-dimensional reconstruction techniques from magnetic resonance images","volume":"43","author":"Peterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2015.09.032_bib76","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archpsyc.55.4.326","article-title":"A functional magnetic resonance imaging study of tic suppression in Tourette syndrome","volume":"55","author":"Peterson","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2015.09.032_bib78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2015.01.001","article-title":"Corticostriatal interactions in the generation of tic-like behaviors after local striatal disinhibition","volume":"265","author":"Pogorelov","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2015.09.032_bib79","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.euroneuro.2014.10.007","article-title":"Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome","volume":"24","author":"Rapanelli","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.brainres.2015.09.032_bib81","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib82","series-title":"Dopamine Receptors and Transporters: Function, Imaging, and Clinical Implication","first-page":"369","article-title":"Dopaminergic neurotransmission in Tourette\u05f3s syndrome: a current update","author":"Sah","year":"2002"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib83","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","article-title":"Ziprasidone treatment of children and adolescents with Tourette\u05f3s syndrome: a pilot study","volume":"39","author":"Sallee","year":"2000","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.brainres.2015.09.032_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.890090307","article-title":"Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons","volume":"9","author":"Sheldon","year":"1991","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2010.06.007","article-title":"Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal","volume":"643","author":"Shirasaki","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.2008.00807.x","article-title":"A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence","volume":"33","author":"Simpson","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.brainres.2015.09.032_bib87","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.mehy.2009.11.028","article-title":"Glutamatergic modulatory therapy for Tourette syndrome","volume":"74","author":"Singer","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.brainres.2015.09.032_bib88","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archpsyc.1992.01820090018003","article-title":"Cerebral glucose metabolism in childhood-onset obsessive\u2013compulsive disorder. Revisualization during pharmacotherapy","volume":"49","author":"Swedo","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2015.09.032_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2005.05.003","article-title":"Using animal models to develop therapeutics for Tourette Syndrome","volume":"108","author":"Swerdlow","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2015.09.032_bib90","first-page":"69","article-title":"Preclinical models relevant to Tourette syndrome","volume":"99","author":"Swerdlow","year":"2006","journal-title":"Adv. Neurol."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2015.09.032_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","article-title":"Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats","volume":"637","author":"Taksande","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2015.09.032_bib92","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1523\/JNEUROSCI.4642-05.2006","article-title":"Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons","volume":"26","author":"Tanabe","year":"2006","journal-title":"J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2015.09.032_bib93","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2008.06.013","article-title":"Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson\u05f3s disease","volume":"589","author":"Tanabe","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib94","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1875397300802010062","article-title":"Glutamatergic synaptic dysfunction and obsessive-compulsive disorder","volume":"2","author":"Ting","year":"2008","journal-title":"Curr. Chem. Genom."},{"key":"10.1016\/j.brainres.2015.09.032_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0888-7543(03)00097-1","article-title":"Tourette Syndrome Association International Consortium for Genetics. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder","volume":"82","author":"Verkerk","year":"2003","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/FBP.0b013e32832a80ad","article-title":"Assessing the validity of current mouse genetic models of obsessive\u2013compulsive disorder","volume":"20","author":"Wang","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib97","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1176\/appi.ajp.2011.09111692","article-title":"The neural circuits that generate tics in Tourette\u05f3s syndrome","volume":"168","author":"Wang","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2015.09.032_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(92)90452-L","article-title":"Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha1-receptor antagonist prazosin","volume":"42","author":"Wellman","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2015.09.032_bib99","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0091-3057(96)00351-6","article-title":"Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats","volume":"57","author":"Wellman","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.brainres.2015.09.032_bib100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats","volume":"282","author":"Willins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5279","key":"10.1016\/j.brainres.2015.09.032_bib101","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","article-title":"Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding","volume":"273","author":"Wolf","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.brainres.2015.09.032_bib102","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2015.09.032_bib103","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1073\/pnas.1419533112","article-title":"Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2015.09.032_bib104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neulet.2015.03.067","article-title":"Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear","volume":"595","author":"Xu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2015.09.032_bib105","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/endo.138.8.5347","article-title":"Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice","volume":"138","author":"Zeiger","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.brainres.2015.09.032_bib106","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjp.0702429","article-title":"Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A adrenoceptor transgenic mice","volume":"126","author":"Zhu","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2015.09.032_bib107","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1176\/ajp.154.9.1277","article-title":"Decreased motor inhibition in Tourette\u05f3s disorder: evidence from transcranial magnetic stimulation","volume":"154","author":"Ziemann","year":"1997","journal-title":"Am. J. Psychiatry"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315007301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315007301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:16:17Z","timestamp":1748643377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899315007301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":107,"alternative-id":["S0006899315007301"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2015.09.032","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"Hyperglutamatergic cortico-striato-thalamo-cortical circuit\" breaker drugs alleviate tics in a transgenic circuit model of Tourette\u05f3s syndrome","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2015.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}